Back

Comparison of the predictive role of changes in left ventricular mass and arterial stiffness for coronary artery disease in essential hypertension: Data from a 8-year-follow-up study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Hypertension mediated target organ damage and hypertension phenotypes Target Organ Damage/Left Ventricular Hypertrophy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ioannis Leontsinis

Hippokration General Hospital, Athens (Greece)

13 More presentations in this session

Presentation thumbnail
The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients
Doctor A. Farcas (Cluj Napoca, RO)
Abstract
Presentation thumbnail
Assessment of carotid cross sectional area in hypertensive patients: phenotyping and prognostic validation in the campania salute network
Doctor C. Mancusi (Napoly, IT)
Abstract
Presentation thumbnail
High level of the amount of ECG peaks SV1+RV5-V6 predict new cases of hypertension in the organized population of the petrochemical industry workers
Doctor A. Ukla (Gomel, BY)
Presentation thumbnail
Prevalence of left atrial enlargement in patients undergoing an echocardiogram for cardiovascular risk stratification at an esh excellence centre in italy
Professor M. Muiesan (Brescia, IT)
Abstract
Presentation thumbnail
Left atrial dysfunction is a potent predictor of ischemic complications in hypertensive patients
Associate Professor D. Shorikova (Chernivtsi, UA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Hypertension mediated target organ damage and hypertension phenotypes

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
How does imaging guide management in my patients with hypertension?
thumbnail
Congress Presentation
Arterial hypertension
thumbnail
Congress Presentation
Left ventricular hypertrophy, wall thickness, and histological myocyte alteration in end-stage heart failure: a call for a standard definition

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources